These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 18685282

  • 1. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
    Akar NA, Adekile A.
    Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
    [Abstract] [Full Text] [Related]

  • 2. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia.
    Athale UH, Chintu C.
    East Afr Med J; 1994 Jun; 71(6):388-91. PubMed ID: 7835262
    [Abstract] [Full Text] [Related]

  • 3. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
    Mellouli F, Bejaoui M.
    Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
    [Abstract] [Full Text] [Related]

  • 4. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH, Al-Dabbous IA.
    Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Mar; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE.
    J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
    [Abstract] [Full Text] [Related]

  • 9. Hospitalisations for sickle-cell disease in an Australian paediatric population.
    Teoh Y, Greenway A, Savoia H, Monagle P, Roy J, Barnes C.
    J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
    [Abstract] [Full Text] [Related]

  • 10. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P, Alyaarubi S, Abish S, Gale M, Albuquerque P, Jabado N.
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Stallworth JR, Jerrell JM, Tripathi A.
    Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
    [Abstract] [Full Text] [Related]

  • 12. Impact of environmental tobacco smoke on children with sickle cell disease.
    West DC, Romano PS, Azari R, Rudominer A, Holman M, Sandhu S.
    Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1197-201. PubMed ID: 14662575
    [Abstract] [Full Text] [Related]

  • 13. Examining the effectiveness of hydroxyurea in people with sickle cell disease.
    Lanzkron S, Haywood C, Fagan PJ, Rand CS.
    J Health Care Poor Underserved; 2010 Feb; 21(1):277-86. PubMed ID: 20173269
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
    Hijazi Z, Onadeko BO, Khadadah M, Haider MZ, Adekile AD, Al-Habashi H.
    Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
    [Abstract] [Full Text] [Related]

  • 15. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID, Woodward M, Reed GW.
    Pediatr Blood Cancer; 2005 Oct 15; 45(5):716-24. PubMed ID: 15926170
    [Abstract] [Full Text] [Related]

  • 16. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL, Kamdar A, Beavers MB, Mahoney DH, Mueller BU.
    Pediatr Blood Cancer; 2008 Jul 15; 51(1):82-5. PubMed ID: 18383165
    [Abstract] [Full Text] [Related]

  • 17. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
    Raphael JL, Kamdar A, Wang T, Liu H, Mahoney DH, Mueller BU.
    Pediatr Blood Cancer; 2008 Sep 15; 51(3):398-401. PubMed ID: 18300322
    [Abstract] [Full Text] [Related]

  • 18. [Effect of hydroxyurea on hemoglobin S].
    Torres AF, Eberle SE, Sciuccati G, Bonduel M.
    Medicina (B Aires); 2003 Sep 15; 63(2):140-2. PubMed ID: 12793083
    [Abstract] [Full Text] [Related]

  • 19. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
    Tavakkoli F, Nahavandi M, Wyche MQ, Castro O.
    Clin Ther; 2005 Jul 15; 27(7):1083-8. PubMed ID: 16154487
    [Abstract] [Full Text] [Related]

  • 20. Admission and length of stay due to painful vasoocclusive crisis in children.
    Rogovik AL, Li Y, Kirby MA, Friedman JN, Goldman RD.
    Am J Emerg Med; 2009 Sep 15; 27(7):797-801. PubMed ID: 19683107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.